Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Finished Goods (2024 - 2026)

PROCEPT BioRobotics has reported Finished Goods over the past 3 years, most recently at $41.4 million for Q1 2026.

  • Quarterly Finished Goods rose 28.35% to $41.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $41.4 million through Mar 2026, up 28.35% year-over-year, with the annual reading at $38.6 million for FY2025, 45.63% up from the prior year.
  • Finished Goods was $41.4 million for Q1 2026 at PROCEPT BioRobotics, up from $38.6 million in the prior quarter.
  • Over five years, Finished Goods peaked at $41.4 million in Q1 2026 and troughed at $26.5 million in Q4 2024.
  • The 3-year median for Finished Goods is $36.3 million (2025), against an average of $35.2 million.
  • Year-over-year, Finished Goods skyrocketed 45.63% in 2025 and then rose 28.35% in 2026.
  • A 3-year view of Finished Goods shows it stood at $26.5 million in 2024, then skyrocketed by 45.63% to $38.6 million in 2025, then rose by 7.09% to $41.4 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Finished Goods are $41.4 million (Q1 2026), $38.6 million (Q4 2025), and $35.5 million (Q3 2025).